Optimizing Spiritual Care Scheduling In Hospitals With Software

Mid-sized hospitals are piloting new software to streamline chaplaincy scheduling and documentation, addressing outdated paper-based processes.

Galibra Neuroscience Receives FDA Orphan Drug And Rare Pediatric Disease Designations For SSADH Deficiency Gene Therapy

Galibra Neuroscience awarded FDA orphan drug and rare pediatric disease designations for its SSADH deficiency gene therapy, advancing its development pipeline.

TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation Of Breaches Of Fiduciary Duties By The Directors And Officers Of TransMedics Group, Inc. – TMDX

Rosen Law Firm announces investigation into possible breaches of fiduciary duties by TransMedics Group directors and officers, prompting legal review.

FAIR Health NSA And Allowed Data Products May Be Introduced In IDR Proceedings To Support Offers, And IDR Entities May Consult FAIR Health Data To Validate Party Submissions

FAIR Health NSA and allowed data products could be introduced in IDR proceedings to support offers, with entities permitted to consult FAIR Health data for validation.

Anonymous daily check-ins for 12-step sponsors

A new pseudonymous check-in system for AA and NA sponsors is being tested to enhance privacy and support for multiple sponsees, amid shifting recovery support tools.

Qnovia Secures Worldwide Exclusive License To Novel Antimicrobial Peptide From The University Of Virginia

Qnovia has obtained a worldwide exclusive license to a novel antimicrobial peptide from the University of Virginia, expanding its biotech portfolio.

CG Oncology Announces Publication Of Pivotal Phase 3 BOND-003 Cohort C Study Results In The Lancet Oncology

CG Oncology announced the publication of pivotal Phase 3 BOND-003 Cohort C study results in The Lancet Oncology, confirming key findings for its cancer therapy.

Ascentage Pharma Chairman And CEO Dr. Dajun Yang Named To The Medicine Maker Power List 2026

Ascentage Pharma CEO Dr. Dajun Yang has been recognized in The Medicine Maker Power List 2026, highlighting his influence in pharmaceutical innovation.

Johnson Johnson Surges In Global Coverage

Johnson & Johnson has seen a significant increase in media mentions, with 31 mentions in recent coverage, indicating rising global attention.

Vir Biotechnology, Inc. Files 8-K: Executive Change

Vir Biotechnology has filed an 8-K report with the SEC confirming an executive change. Details are limited, and further updates are expected.